Journal for ImmunoTherapy of Cancer (Nov 2020)
112 Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)